Advanced Enzyme Technologies Limited

Equities

ADVENZYMES

INE837H01020

Specialty Chemicals

Market Closed - NSE India S.E. 07:43:46 2024-04-26 am EDT 5-day change 1st Jan Change
391.8 INR +1.41% Intraday chart for Advanced Enzyme Technologies Limited +6.96% +4.37%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Advanced Enzyme Technologies Limited Announces Cessation of Kedar J. Desai as Independent Director CI
Advanced Enzyme Completes Acquisition of Additional 5.9% Stake in Subsidiary JC Biotech MT
Advanced Enzyme Technologies Limited acquired additional 5.89% stake in Jc Biotech Private Limited for INR 56.1 million CI
Transcript : Advanced Enzyme Technologies Limited, Q3 2024 Earnings Call, Feb 16, 2024
Advanced Enzyme Technologies to Lift Stake in JC Biotech to Nearly 96% MT
Advanced Enzyme Technologies Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Advanced Enzyme Technologies Limited agreed to acquire additional 5.89% stake in Jc Biotech Private Limited for INR 56.1 million. CI
Crisil Keeps A+ Rating on Advanced Enzyme Technologies' Bank Loans; Outlook Stable MT
Transcript : Advanced Enzyme Technologies Limited, Q2 2024 Earnings Call, Nov 10, 2023
Advanced Enzyme Technologies Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Transcript : Advanced Enzyme Technologies Limited, Q1 2024 Earnings Call, Aug 16, 2023
Advanced Enzyme Technologies Declares Final Dividend for the Financial Year Ended March 31, 2023 CI
Transcript : Advanced Enzyme Technologies Limited - Shareholder/Analyst Call
Advanced Enzyme Technologies Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Advanced Enzyme Technologies Limited Proposes Dividend Payable on or After August 16, 2023 CI
Transcript : Advanced Enzyme Technologies Limited, Q4 2023 Earnings Call, May 15, 2023
Advanced Enzyme Technologies Limited Announces Board Changes CI
Advanced Enzyme Technologies Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023 CI
Advanced Enzyme Technologies Limited Recommends Final Dividend for the Financial Year 2022-23; Declares an Interim Dividend for the Financial Year 2023-24, Payable on or Before June 11, 2023 CI
Transcript : Advanced Enzyme Technologies Limited, Q3 2023 Earnings Call, Feb 14, 2023
Advanced Enzyme Technologies' Overseas Units Get Board Nod for Proposed Merger MT
Advanced Enzyme Technologies Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
Advanced Enzyme Completes Acquisition of Stakes in Saiganesh Enzytech, JC Biotech MT
Advanced Enzyme Technologies Limited completed the acquisition of additional 4.83% stake in JC Biotech Private Limited. CI
Transcript : Advanced Enzyme Technologies Limited, Q2 2023 Earnings Call, Nov 15, 2022
Chart Advanced Enzyme Technologies Limited
More charts
Advanced Enzyme Technologies Limited is an India-based company, engaged in manufacturing enzymes and probiotics. The Company is focused on the research and development, manufacturing, and marketing of approximately 400 products, which is developed from over 68 indigenous enzymes and probiotics. It provides solutions to various industries, such as human health care and nutrition, animal nutrition, baking, fruit, and vegetable processing, brewing, and malting, grain processing, protein modification, dairy processing, textile processing and others. It offers products and solutions for human nutrition, which include serratiopeptidase, fungal lactase, fungal lipase, and papain; animal nutrition, which include DigeGrain X, DigeGrain XL and DigeGrain M; food processing, including dairy and cheese processing and yeast processing, and non-food processing, including textiles processing, leather, and biofuels. Its oils and fats processing include oil extraction, oil refining, and others.
More about the company

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. ADVENZYMES Stock
  4. News Advanced Enzyme Technologies Limited
  5. Advanced Enzyme Completes Acquisition of Additional 5.9% Stake in Subsidiary JC Biotech